About
Robert A. Aspbury, Ph.D., has served as President of Certara Predictive Technologies (formerly the Scientific Software and Simcyp division) since January 2020, after serving as Chief Operating Officer of Simcyp from April to December 2019. Before joining Certara he was Vice President of Strategic Solutions, Biosimilars at Covance and held multiple senior commercial and finance roles there over more than 17 years. He is a qualified chartered accountant and holds a doctorate from the University of Liverpool.
Roles
Certara, Inc.
President, Certara Predictive Technologies · Current role
2020–present
Simcyp
Chief Operating Officer (2019)
—
Covance Inc.
VP, Strategic Solutions, Biosimilars; VP & GM, Global Clinical Pharmacology
—
Simcyp
Chief Operating Officer
—
Covance
VP, Biosimilars Strategic Solutions; VP/GM; Managing Director
—
Fixed Compensation
FY 2025
All other compensation
$37,073
Total compensation
$2,025,868
Performance Compensation
Data from FY 2025
Cash incentive
Annual incentive bonus
$331,386
Stock awards
Long-term equity awards
$1,199,743